News

The University of Oxford has launched a Phase I trial of a novel mosaic vaccine targeting a ‘broad range’ of HIV variants. The HIV-CORE 0052 trial, part of the European Aids Vaccine Initiative, will involve 13 healthy HIV-negative adults aged...

The dosage of Fenbendazole depends upon the health condition of the patient, already prescribed medicines, and/or chemotherapy. Dosage may vary for every human being. Dosage guide: Note: Consultation with a professional is very important. The dosage depends on chemotherapy, additional drugs,...

Alvotech, the Iceland-based biosimilar company, announced that the first patient has been dosed in the comparative, confirmatory efficacy and safety clinical study (AVT04-GL-301) for AVT04, Alvotech's proposed biosimilar to the reference product Stelara®. The objective of the study is...

Zydus Cadila announced that the company has applied for EUA to the office of Drug Controller General of India (DCGI) for ZyCoV-D -its Plasmid DNA Vaccine against COVID-19. The company conducted the largest clinical trial for its COVID-19 vaccine...

Menzies Aviation, the global aviation logistics specialist, is delighted to announce that its cargo operations have received a further Center of Excellence of Independent Validators for Pharmaceutical Logistics accreditation (“CEIV Pharma”) as recognised by IATA. This accreditation is for...

July 6, 1885 was a historic date for modern medicine and treatment. This was the day when Louis Pasteur administered the first attenuated vaccine to a human patient. Over the next 135 years, the development of vaccines for various...

Roche is teaming up with Mimetas, a provider of organ-on-chip-based disease model to develop human disease models to characterize novel compounds in inflammatory bowel disease (IBD) and hepatitis B virus infections (HBV). The collaboration will see Mimetas developing tissue-based disease...